The Brief Brief Longevity
the slow science of staying alive longer.
Longevity — briefly, then briefly again · tbb.ceo
listen tothe daily 0:00 –:––
/daily ·21 OCT 2026 ·WEDNESDAY ·2 MIN READ ·5 STORIES

Wednesday: Reprogramming Reaches Humans, Lifespan Extends in Mice

The first in-human data from an epigenetic reprogramming trial came in, a single splicing factor extended mouse lifespan by 14% without erasing cell identity, and a 194-year-old tortoise gave up its genome.

01 / The Day

WEDNESDAY 21 OCT 2026, ranked

05

First Epigenetic Reprogramming Trial Returns Human Safety Data

Life Biosciences reported Phase 1 interim results for ER-100, a partial epigenetic reprogramming therapy for optic neuropathies: the treatment was well tolerated through day 56 in all three participants, and visual field improvements were observed in two of three glaucoma patients.

  • ER-100 is delivered intraocularly and targets retinal ganglion cells using a partial OSKM reprogramming approach
  • No serious adverse events in any of the three participants through day 56; visual field testing showed improvement in two of three glaucoma cases
  • This is the first published safety readout in humans for the partial reprogramming therapeutic class that has extended lifespan in animal models
Why it mattersEvery longevity intervention is waiting on whether partial reprogramming — which works in mice — is safe in humans. This is the first data point from that experiment.
01 fightaging.org↗

Splicing Factor SRSF1 Extends Mouse Median Lifespan by 14%

Researchers at the Wyss Institute, Harvard Medical School, and CIC bioGUNE identified SRSF1 — an RNA splicing factor — as a regulator of cellular ageing that restores youthful gene-expression patterns in mice without the dedifferentiation risk of Yamanaka-factor reprogramming; AAV-delivered SRSF1 extended median lifespan by 14% and reduced senescence markers by approximately 70% in aged mice.

  • SRSF1 identified via machine-learning transcriptomic aging clock screen, not conventional pathway hypothesis
  • Overexpression restores youthful gene-expression signatures without erasing cell identity or raising oncogenesis risk, unlike OSKM reprogramming
  • AAV liver-targeted delivery demonstrated 44% reduction in systemic frailty progression alongside the lifespan extension; results published in Nature Aging
Why it mattersA single splicing factor that rejuvenates cells without the identity-erasure risk that has been reprogramming's main safety barrier shifts the field's search space significantly.
02 doi.org↗

Gut Microbiome Composition Predicts Inflammation Better Than Chronological Age

In 1,199 adults from the DanFunD cohort, gut microbiome composition predicted variation in inflammatory cytokine levels and physiological ageing measures more accurately than chronological age alone, with the Bacteroides 2 enterotype linked to elevated systemic inflammation beginning in early adulthood.

  • Microbiome data explained more cytokine variance than age for most measured inflammatory markers in the 1,199-person DanFunD cohort
  • Bacteroides 2 enterotype associated with higher systemic inflammation from early adulthood — decades before clinical disease presentation
  • Results suggest microbiome profiling may serve as an earlier, more sensitive biomarker of inflammatory ageing trajectory than birth year
Why it mattersIf the microbiome is a more accurate predictor of inflammatory ageing than chronological age, it becomes a far more actionable target — bacterial composition changes on shorter timescales than a birthday.
03 fightaging.org↗

Genome of a 194-Year-Old Tortoise Reveals Longevity-Associated Variants

Researchers sequenced the genome of Jonathan — the Aldabra giant tortoise estimated at 194 years old and the world's oldest known living land animal — finding unique gene variants and DNA methylation patterns concentrated in mitochondrial and RNA metabolism gene promoters that may contribute to extreme lifespan.

  • Jonathan's genome compared with other giant tortoise individuals; unique low-entropy gene promoters identified in mitochondrial metabolism and RNA processing pathways
  • DNA methylation differences in these regions suggest distinct epigenetic regulation of metabolic ageing in giant tortoises versus shorter-lived species
  • Study uses Jonathan's well-documented health records and known estimated birth year as a phenotypic anchor for variant-to-outcome correlation
Why it mattersGiant tortoises age roughly ten times more slowly than humans; genomic variants that differ from shorter-lived relatives mark candidate longevity pathways worth examining in mammalian biology.
04 fightaging.org↗

mRNA Therapy Reprograms Natural Killer Cells In Situ Against Tumours

Researchers used lipid nanoparticles carrying chimeric antigen receptor mRNA to reprogram a host's own natural killer cells inside the body to target tumour cells, achieving approximately 80% NK cell reprogramming efficiency and tumour remission in melanoma and lymphoma mouse models.

  • In situ mRNA delivery avoids the ex vivo cell manufacturing step that limits current CAR-T and CAR-NK therapies
  • Approximately 80% of targeted NK cells were successfully reprogrammed in mouse models; autoreactive T cells were also eliminated in an autoimmune hepatitis model
  • The same delivery platform was applied to both cancer and autoimmune disease targets in the same study
Why it mattersIf the platform translates to humans, it would convert patients' own immune cells into precision oncology tools without the cell-manufacturing bottleneck that currently limits who can access CAR therapy.
05 fightaging.org↗
Be subscriber #022 the weekly ten, every friday by email · no spam · unsubscribe anytime
Past days

The Daily Archive

/FRI 30 OCTFour Aging Mechanisms, All Fresh/WED 28 OCTWednesday: Bone Mechanics, Zombie Cells, and a Triple Agonist/MON 26 OCT2026-10-26/FRI 23 OCTSignals, Clearance, and Clock Caveats/WED 21 OCTWednesday: Reprogramming Reaches Humans, Lifespan Extends in Mice/MON 19 OCTCentenarian Signatures/FRI 16 OCTMuscles, Autophagy, and the Peptide Policy Push/WED 14 OCTCysteine, Centenarians, and Senescent Discs/MON 12 OCTT cells, lipids, and the gut-brain aging axis/FRI 09 OCTClocks, Genomes, and Repair/WED 07 OCTThe Long Lipid Edition/MON 05 OCTMonday Deep Reads/FRI 02 OCTFriday in Longevity: AMPK delivers, FDA maps the path/WED 30 SEPTTau tangles, mTOR complexity, and ultraprocessed food/MON 28 SEPTMitochondria, Dendritic Cells, and the Case for Creatine/WED 23 SEPTAging's Molecular Clock: Six Studies That Move the Field/MON 21 SEPTGLP-1 clears the aging bar; a new immune evasion mechanism in senescent cells/FRI 18 SEPTThe calorie clock, the muscle leak, and the microprotein atlas/WED 16 SEPTTwo New Senescence Targets, Brain Clocks, and Cancer's Age Connection/MON 14 SEPTThe SASP Dial/FRI 11 SEPTThe Senolytic Score